Analysed CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) News Sources
Cardiol Therapeutics Fiscal 2025 Loss Narrows; Says Now Fully Funded Through Completion of MAVERIC trial
01-04-2026
yahoo.com
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference
08-03-2026
marketbeat.com
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
10-02-2026
yahoo.com
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
23-01-2026
yahoo.com
Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
16-01-2026
yahoo.com
Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million
16-01-2026
yahoo.com
What is the current price of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?
The current price of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is $1.38.
CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) since the previous trading day is $0.
CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?
The most recent average sentiment score for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)?
The most recent sentiment for CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ) is .
SEC-8K** Filing Available For CARDIOL THERAPEUTICS INC-A (CRDL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.